Raymond James Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248M Buy
3,459,485
+14,296
+0.4% +$1.1M 0.08% 229
2025
Q4
$273M Buy
3,445,189
+344,071
+11% +$27.1M 0.09% 207
2025
Q3
$234M Sell
3,101,118
-90,466
-3% -$6.2M 0.08% 236
2025
Q2
$220M Buy
3,191,584
+133,875
+4% +$8.78M 0.08% 234
2025
Q1
$207M Buy
3,057,709
+472,880
+18% +$28.3M 0.08% 233
2024
Q4
$116M Buy
+2,584,829
New +$145M 0.04% 383

Other funds holding CVS

Raymond James Financial's CVS Position: Q1 2026 in Review

Raymond James Financial increased its CVS Health (CVS) stake by 0.41% in Q1 2026, buying an estimated $1.1M and bringing the position to 3,459,485 shares worth $248M. The position accounts for 0.08% of the portfolio, ranked #229.

Raymond James Financial first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $273M in Q4 2025. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Raymond James Financial held 3,459,485 shares of CVS Health worth $248M as of Q1 2026.
  • Raymond James Financial bought 14,296 CVS Health shares in Q1 2026, an estimated $1.1M.
  • CVS Health made up 0.08% of Raymond James Financial's portfolio in Q1 2026, its #229 holding.
  • Raymond James Financial first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's CVS Health position peaked at $273M in Q4 2025.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.